Suchergebnisse - "Yamada, Daisaku"

PubPharm (19)

1

Removal of gemcitabine-induced senescent cancer cells by targeting glutaminase1 improves the therapeutic effect in pancreatic ductal adenocarcinoma

enthalten in: International journal of cancer | 2024

von Oyama, K. | Iwagami, Y. | Kobayashi, S. | +9

2

Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Nishi, H. | Gotoh, K. | Tomimaru, Y. | +11

3

Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy

enthalten in: International journal of clinical oncology | 2023

von Marukawa, D. | Gotoh, K. | Kobayashi, S. | +11

4

ASO Author Reflections : ACAT-1-Regulated Cholesteryl Ester Accumulation Modulates Gemcitabine Resistance in Biliary Tract Cancer

enthalten in: Annals of surgical oncology | 2022

von Ueno, G. | Iwagami, Y. | Kobayashi, S. | +10

CommentOn: Ann Surg Oncol. 2022 May;29(5):2899-2909. - PMID 34994902

5

ACAT-1-Regulated Cholesteryl Ester Accumulation Modulates Gemcitabine Resistance in Biliary Tract Cancer

enthalten in: Annals of surgical oncology | 2022

von Ueno, G. | Iwagami, Y. | Kobayashi, S. | +10

CommentIn: Ann Surg Oncol. 2022 May;29(5):2910-2911. - PMID 34994897

6

Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)

enthalten in: Trials | 2021

von Yamada, D. | Kobayashi, S. | Takahashi, H. | +18

7

Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines

enthalten in: Digestive diseases and sciences | 2020

von Kinoshita, M. | Kobayashi, S. | Gotoh, K. | +16

8

Clinical implications of the serum CA19-9 level in "biological borderline resectability" and "biological downstaging" in the setting of preoperative chemoradiation therapy for pancreatic cancer

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2020

von Takahashi, H. | Yamada, D. | Asukai, K. | +16

9

A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma

enthalten in: ChemMedChem | 2019

von Matsushita, K. | Okuda, T. | Mori, S. | +19

10

Successful R0 Resection of Hilar Cholangiocarcinoma by Extrahepatic Bile Duct Resection Due to Accompanying Liver Dysfunction after Neoadjuvant Gemcitabine/Cisplatin/S-1 Combination Chemotherapy-A Case Report

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2019

von Higashiguchi, M. | Yamada, D. | Akita, H. | +11